12-56214032-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005785.4(RNF41):āc.16A>Gā(p.Thr6Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000327 in 1,613,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005785.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF41 | NM_005785.4 | c.16A>G | p.Thr6Ala | missense_variant | 3/7 | ENST00000345093.9 | NP_005776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF41 | ENST00000345093.9 | c.16A>G | p.Thr6Ala | missense_variant | 3/7 | 1 | NM_005785.4 | ENSP00000342755 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152034Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251424Hom.: 0 AF XY: 0.000287 AC XY: 39AN XY: 135882
GnomAD4 exome AF: 0.000344 AC: 503AN: 1461172Hom.: 0 Cov.: 30 AF XY: 0.000349 AC XY: 254AN XY: 726952
GnomAD4 genome AF: 0.000158 AC: 24AN: 152034Hom.: 0 Cov.: 31 AF XY: 0.000189 AC XY: 14AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.16A>G (p.T6A) alteration is located in exon 3 (coding exon 1) of the RNF41 gene. This alteration results from a A to G substitution at nucleotide position 16, causing the threonine (T) at amino acid position 6 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at